Related Experiment Video
Updated: Oct 22, 2025
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
446
Methotrexate Hepatotoxicity Monitoring Guidelines in Psoriasis and Rheumatoid Arthritis: Is There a Consensus?
Dillon D Clary1, Alexander T Reid1, Rabia Kiani1
1Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Summary
Methotrexate monitoring for liver toxicity differs between rheumatology and dermatology guidelines, with dermatology emphasizing risk factors. This review examines the validity of these differing approaches to methotrexate hepatotoxicity screening.
Area of Science:
- Pharmacology
- Hepatology
- Clinical Practice Guidelines
Background:
- Methotrexate is a cornerstone therapy for rheumatoid arthritis and psoriasis.
- Hepatotoxicity is a significant concern associated with methotrexate use.
- Independent monitoring guidelines for methotrexate liver toxicity exist for rheumatologists and dermatologists.
Purpose of the Study:
- To investigate the reasons behind divergent methotrexate hepatotoxicity screening guidelines between dermatology and rheumatology.
- To evaluate the clinical validity of differing risk stratification and screening protocols.
- To briefly explore alternatives to liver biopsy for monitoring methotrexate-induced liver injury.
Main Methods:
- Comparative analysis of existing rheumatology and dermatology methotrexate monitoring guidelines.
- Review of literature on methotrexate hepatotoxicity and risk factors.
- Discussion of the role and limitations of liver biopsy in current screening practices.
Main Results:
- Dermatology guidelines incorporate risk stratification based on factors like alcohol use, obesity, and diabetes.
- Rheumatology guidelines do not prominently feature this risk stratification.
- The review identifies key differences in screening approaches and their potential justifications.
Conclusions:
- The disparity in methotrexate hepatotoxicity screening guidelines warrants further investigation into their clinical validity.
- Understanding these differences is crucial for optimizing patient safety and treatment efficacy.
- Alternative screening methods to liver biopsy may offer valuable adjuncts to current monitoring strategies.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
32
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
32
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
290
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
290
01:16Therapeutic Drug Monitoring: Overview and Classification
48
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
48
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
36
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
36
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
30
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
30
01:21Rheumatic Heart Disease III: Medical Management
65
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
65